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Ureteric bud branchingThe glial cell line-derived neurotrophic factor (GDNF)/RET tyrosine kinase signaling pathway plays crucial
roles in the development of the enteric nervous system (ENS) and the kidney. Tyrosine 1062 (Y1062) in RET is
an autophosphorylation residue that is responsible for the activation of the PI3K/AKT and RAS/MAPK signaling
pathways. Mice lacking signaling via Ret Y1062 show renal hypoplasia and hypoganglionosis of the ENS
although the phenotype is milder than the Gdnf- or Ret-deﬁcient mice. Sprouty2 (Spry2) was found to be an
antagonist for ﬁbroblast growth factor receptor (FGFR) and acts as an inhibitory regulator of ERK activation.
Spry2-deﬁcient mice exhibit hearing loss and enteric nerve hyperplasia. In the present study, we generated
Spry2-deﬁcient and Ret Y1062F knock-in (tyrosine 1062 is replaced with phenylalanine) double mutant mice
to see if abnormalities of the ENS and kidney, caused by loss of signaling via Ret Y1062, are rescued by a
deﬁciency of Spry2. Double mutant mice showed signiﬁcant recovery of ureteric bud branching and ENS
development in the stomach. These results indicate that Spry2 regulates downstream signaling mediated by
GDNF/RET signaling complex in vivo.Nagoya University Graduate
466-8550, Japan. Fax: +81 52
akahashi).
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The RET proto-oncogene encodes a receptor tyrosine kinase that
regulates cellular proliferation, differentiation, survival, and motility
(Asai et al., 2006; Ichihara et al., 2004). RET is activated by GDNF
family ligands, including GDNF, neurturin, artemin, and persephin.
These ligands do not bind to RET directly but initially interact with
glycosylphosphatidylinositol-linked cell surface proteins called GDNF
family receptor alpha (GFRα) (Airaksinen and Saarma, 2002;
Takahashi, 2001). GDNF, neurturin, artemin, and persephin preferen-
tially bind to GFRα1, GFRα2, GFRα3, and GFRα4, respectively. Ligand
binding to a co-receptor induces RET dimerization, which leads to the
autophosphorylation of intracellular tyrosine residues. We found that
tyrosine1062 (Y1062) in RET is an important phosphorylation site
responsible for the activation of the RAS/ERK and PI3K/AKT signaling
cascades (Hayashi et al., 2000). Mice lacking Ret die within the ﬁrst12–24 hafter birth and showrenal agenesis or severe hypogenesis and a
loss of enteric ganglia throughout the digestive tract (Schuchardt et al.,
1994). Gdnf- or Gfrα1-deﬁcient mice exhibit similar phenotypes as Ret-
deﬁcient mice (Cacalano et al., 1998; Enomoto et al., 1998; Moore et al.,
1996; Pichel et al., 1996; Sánchez et al., 1996). Previously, we and other
groups generatedRetY1062Fknock-inmice (Y1062Fmice) inwhichRet
Y1062 was replaced with phenylalanine (Jain et al., 2006; Jijiwa et al.,
2004; Wong et al., 2005). Homozygous Y1062Fmice that we generated
show growth retardation and die within 1 month after birth.
Histological analyses suggested that these mice have impairments in
theproliferation and/ormigration of entericneural crest cells, branching
of ureteric buds during embryogenesis, and self-renewal of spermato-
gonial stem cells after birth (Jijiwa et al., 2004, 2008). GDNF-mediated
phosphorylation of ERK and AKT in dorsal root ganglia cells is
signiﬁcantly decreased in Y1062F homozygous mice, suggesting the
importance of these signaling cascades for organogenesis.
Sprouty (Spry)wasﬁrst isolated inDrosophila as a negative regulator
of FGF signaling during tracheal development and was subsequently
shown to be a general receptor tyrosine kinase (RTK) inhibitor
(Hacohen et al., 1998; Reich et al., 1999). Four mammalian Spry
homologues (Spry 1–4) have been identiﬁed, and all are expressed
during embryogenesis (de Maximy et al., 1999; Tefft et al., 1999).
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homologs of Spry have a C-terminal cysteine-rich domain that is similar
to the cognate domain within dSpry (Hacohen et al., 1998). However,
similarity in their N termini is limited. Spry inhibits RTK-mediated ERK
activation through multiple mechanisms. For example, Spry has been
shown to bind to Raf, TESK1, DRYK1A, Cbl, and PI(4,5)P2 (Edwin et al.,
2009). We have shown that Spry2 inhibits GDNF-induced ERK
activation in TGW human neuroblastoma cells and that the forced
expression of wild-type Spry2 reduces GDNF-dependent neurite
outgrowth of TGW cells (Ishida et al., 2007). However, the precise
molecularmechanism bywhich Spry inhibits the RTK pathway remains
controversial.
Spry 1, 2, and 4 are expressed in several developing organs
including the brain, cochlea, nasal organs, teeth, salivary gland, lung,
digestive tract, kidney, and limb buds. In the kidney, Spry1 expression
is prominent in the ureteric bud, whereas Spry2 and 4 are expressed in
both the ureteric bud and the kidney mesenchyme (Zhang et al.,
2001). Spry2-deﬁcient mice have been generated by two groups
independently. Shim et al. (2005) demonstrated that lack of Spry2
causes a cytoarchitecture-based anomaly in the organ of Corti due to
the deregulation of FGF signaling. Taketomi et al. (2005) reported that
Spry2-deﬁcient mice exhibit hyperganglionosis of the intrinsic ENS,
resulting in esophageal achalasia and intestinal pseudo-obstruction.
Intriguingly, in the latter report, treatment with an anti-GDNF
antibody corrected enteric nerve hyperplasia and esophageal dilation,
suggesting that Spry2 is a negative regulator of GDNF/RET signaling.
Based on these ﬁndings, we hypothesized that the loss of Spry2 in Ret
Y1062F knock-in mice will increase ERK signaling, rescuing the
defects observed in the Y1062F mice. To test this hypothesis, we
generated Spry2-deﬁcient and Ret Y1062F knock-in double mutant
mice and investigated the association between GDNF/RET signaling
and Spry2 in vivo.
Materials and methods
Generation of Spry2 knockout/Ret Y1062F knock-in double mutant mice
Ret Y1062F knock-in mice and Spry2 knockout mice were generated
as described previously (Jijiwa et al., 2004; Taketomi et al., 2005).
HeterozygousY1062Fmice andheterozygous Spry2knockoutmicewere
mated to obtain Spry2 knockout/Ret Y1062F knock-in double heterozy-
gous mice (Spry2 +/-/Ret+/Y1062F, He/He). The He/He mice were crossed
to generate Spry2 knockout/Ret Y1062F knock-in double homozygous
mice (Spry2−/−/RetY1062F/Y1062F, Ho/Ho). All animal protocols were
approved by the Animal Care and Use Committee of Nagoya University
Graduate School of Medicine.
Genotyping of mice
Genomic DNA of new born mice was extracted from the tail. Mice
with a mutant Spry2 allele were screened by genomic PCR with the
forward primer (5′-AACACACTGCCAAGACCTGA-3′), reverse primer 1
(5′-TAGGCATGCAGACCCAAATC-3′, wild-type speciﬁc) and reverse
primer2(5′-CGAGATCAGCAGCCTCTGTT-3′, knockout speciﬁc) (Taketomi
et al., 2005). Mice with mutant Ret allele were screened by genomic PCR
with the forward primer (5′-ACTACTTGGACCTGGCTGCATCCA-3′) and
reverse primer (5′-GAAAAGGGTTCGGAGGAGGCTTTGGTGTCG-3′), fol-
lowed by SspI digestion, which can speciﬁcally digest the ampliﬁed
mutant allele (Jijiwa et al., 2004).
Histological analysis
Because of the decrease in survival period of Spry2 knockout/Ret
Y1062F knock-in double mutant mice, phenotypical analysis was
performed at postnatal day 0 (P0). After body weight measurement,
mice were sacriﬁced under general anesthesia with diethyl ether. Anautopsy was performed, and the major organs were dissected for
histological analysis. All tissues were ﬁxed in 10% neutral-buffered
formalin, dehydrated, and embedded in parafﬁn. Five-micrometer
-thick sections were prepared for hematoxylin and eosin staining and
immunohistochemistry. Ureteric bud branching was quantiﬁed with
kidney sections cut in the longest axis. The number of ureteric buds
per millimeter squared was counted. The thickness of the subcapsular
domain between the tip of ureteric bud and the renal surface was
measured and analyzed using WINROOF software (Mitani Corpora-
tion, Fukui, Japan).
Immunohistochemistry
Slides were deparafﬁnized in xylene and rehydrated in a graded
series of ethanol. For antigen retrieval, sections were incubated in
0.01 M citrate buffer (pH6.0) and heat-treated in a microwave oven for
15 min. Endogenous peroxidase was inhibited with 3% H2O2 for 10 min
at room temperature. Nonspeciﬁc binding sites were blocked with 10%
normal goat serum for 60 min at room temperature. The sections were
incubated with a rabbit anti-RET polyclonal antibody (R787, Immuno-
Biological Laboratories, Japan), a rabbit anti-phospho-ERK1/2polyclonal
antibody (#9101, Cell Signaling Technology), or a rabbit anti-Protein
Gene Product 9.5 (PGP9.5, UltraClone Limited, UK) polyclonal antibody
overnight at 4 °C andwere then incubatedwith EnVision+system-HRP
(DAKO) for 60 min at room temperature. To visualize the sections, DAB
staining (Wako) was performed according to the manufacturer's
instructions. All sections were counter-stained with hematoxylin.
Whole-mount NADPH-diaphorase histochemistry
Stomachs and intestines were ﬁxed in 4% paraformaldehyde/PBS
for 1–2 h at 4 °C and incubated in 50 mM Tris buffer (pH 7.4)
containing 0.5 mM MgCl2, 0.3% Triton X-100, 1 mg/ml β-NADPH,
0.5 mg/ml nitroblue tetrazolium at room temperature for 60 min
under dark conditions. Stained specimenswere photographedwith an
Olympus SZX7 stereomicroscope. NADPH-diaphorase-positive neu-
rons in the myenteric plexus were counted in ﬁve randomly selected
areas in the stomach, the small intestine, and the proximal, middle,
and distal parts of the large intestine (a microscopic ﬁeld was
0.0625 mm2) from four to six mice. Moderately to strongly stained
neurons were considered positive.
Primary culture of dorsal root ganglia
Dorsal root ganglia were obtained from mice at P0 under a
stereoscopic microscope and washed twice with ice-cold physiolog-
ical saline and twice with Ham's F-12 (Gibco). They were digested
with 0.15% collagenase and 0.05% trypsin–EDTA, and mechanically
triturated. Isolated cells were suspended in F-12, and 1.5 volumes of
Dulbecco's modiﬁed Eagle's medium supplemented with 8% calf
serum were added. The cells were plated on 35-mm-diameter tissue
culture dishes coated with ﬁltrated 0.01% poly-L-lysine (Sigma) and
maintained in a humidiﬁed incubator with 95% air and 5% CO2 at
37 °C. Themediumwas replacedwith serum-free Dulbecco'smodiﬁed
Eagle'smedium/F-12 (at a ratio of 1.5 to 1) 48 h after the initial plating
and kept for 24 h. Then cultured cells were treated with GDNF
(100 ng/ml) of 15 min, lysed in sodium dodecyl sulfate (SDS) sample
buffer, and subjected to Western blot analysis.
Western blot analysis
Equal amounts of protein were separated by SDS-5~12% polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred to polyvinyli-
dene diﬂuoride membranes (Millipore). Membranes were blocked for
60 min with 5% albumin in TBST buffer (20 mM Tris–HCl; pH 7.6,
137 mM NaCl, 0.1% Tween 20) and incubated with primary antibodies
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three times with TBST, they were incubated with secondary antibodies
for 60 min at RT. After washing the membranes, the reaction was
visualized using the ECL Detection Kit (GE Healthcare, UK). Rabbit anti-
ERK1/2, anti-phosphoERK1/2, anti-AKT, and anti-phospho-AKT poly-
clonal antibodies were purchased from Cell Signaling Technology.
Statistical analysis
Statistical signiﬁcance was evaluated with Student's t-test. Com-
parison between more than two groups was made with one-way
ANOVA by Fisher's post hoc analysis. Pb0.05 was considered
signiﬁcant.
Results
Generation of Spry2 knockout/Ret Y1062F knock-in double mutant mice
When double heterozygous (Spry2 +/-/Ret+/Y1062F) mice were
mated, each genotype was obtained at the expected Mendelian
frequency, suggesting an absence of embryonic lethality associated
with these mutations. The majority of Spry2+/+/Ret+/+ (W/W),
Spry2+/+/Ret+/Y1062F (W/He), and Spry2 +/-/Ret+/Y1062F (He/He)
mice survived longer than 1 year (data not shown). On the contrary,
almost all of the Spry2−/−/Ret+/+ (Ho/W), Spry2+/+/RetY1062F/Y1062F
(W/Ho), and Spry2−/−/RetY1062F/Y1062F (Ho/Ho) mice died within
30 days after birth (Fig. 1). Approximately 70% of Spry2−/−/Ret+/+
(Ho/W) and Spry2−/−/RetY1062F/Y1062F (Ho/Ho) mice died within 24 h
after birth. The survival rate of Spry2+/+/RetY1062F/Y1062F (W/Ho) mice
decreased linearly, consistentwith a previous report (Jijiwa et al., 2004)
and died by 18 days after birth (Fig. 1). Although there was no
signiﬁcant difference in body weight between each genotype at birth
(Fig. 2A), Spry2−/−/Ret+/+, Spry2+/+/RetY1062F/Y1062F, and Spry2−/−/
RetY1062F/Y1062F mice showed growth retardation from birth onward
(data not shown).
Renal phenotype of Spry2 knockout/Ret Y1062F knock-in double mutant
mice
Consistent with our previous report (Jijiwa et al., 2004), kidney
weight in Spry2+/+/RetY1062F/Y1062F mice was signiﬁcantly smaller
than in wild-type (W/W) mice (Fig. 2B). Spry2+/+/RetY1062F/Y1062F
mice showed a 38% decrease in the ratio of kidney weight to bodyFig. 1. Survival rates of mutant mice. The survival rates of Spry2+/+/Ret+/+ (W/W),
Spry2−/−/Ret+/+ (Ho/W), Spry2+/+/RetY1062F/Y1062F (W/Ho), and Spry2−/−/
RetY1062F/Y1062F (Ho/Ho) mice are shown as percentages of the mice alive at each
time point.weight compared with wild-typemice (Fig. 2C). Intriguingly, the ratio
in Spry2−/−/RetY1062F/Y1062F mice signiﬁcantly increased compared
with Spry2+/+/RetY1062F/Y1062F mice (Fig. 2C). There was no signiﬁcant
difference in the ratio of heart weight to body weight between each
genotype (Fig. 2D).
Histologically, Spry2+/+/RetY1062F/Y1062F mice showed a 47%
reduction in the number of ureteric bud tips per millimeter squared
compared with that of wild-type mice (Fig. 3A, B, Pb0.05) and
displayed some cystic tubules (Supplementary Fig. 1). The number of
ureteric bud tips per millimeter squared in Spry2−/−/RetY1062F/Y1062F
mice was signiﬁcantly greater than that in Spry2+/+/RetY1062F/Y1062F
mice (Fig. 3A, B, 51% increase), but less than that in wild-type mice
(Fig. 3A, B, 20% decrease). This result was also conﬁrmed by counting
Ret-positive ureteric buds in each genotype.
The formation of cystic tubules in Spry2−/−/RetY1062F/Y1062Fmicewas
less than that seen in Spry2+/+/RetY1062F/Y1062F mice (Supplementary
Fig. 1). In addition, the kidney of Spry2+/+/RetY1062F/Y1062F mice had a
thicker subcapsular domain. The thickness of this domain in Spry2−/−/
RetY1062F/Y1062F mice was signiﬁcantly thinner than that in Spry2+/+/
RetY1062F/Y1062F mice but was still thicker than that in wild-type and
Spry2−/−/Ret+/+ mice (Fig. 3A, C).
It has been reported that MAP kinase regulates branching morpho-
genesis of the ureteric bud (Fisher et al., 2001). To compare the
activation level of ERK in the ureteric bud, immunohistochemical
analysis was performed using serial sections of the P0 kidney.
Phosphorylation of ERK was detected at high levels in the ureteric bud
tips of wild-type (Fig. 4E) and Spry2−/−/Ret+/+ mice (Fig. 4F). ERK
phosphorylation was signiﬁcantly decreased in the tips of Spry2+/+/
RetY1062F/Y1062F mice but was restored in Spry2−/−/RetY1062F/Y1062F mice
(Fig. 4G,H). These data are consistentwith the role of Spry2 as a negative
regulator of ERK activation.
In addition, Ret was highly expressed in the ureteric bud tips of
wild-type (Fig. 4A) and Spry2−/−/Ret+/+ mice (Fig. 4B). By contrast,
Ret expression was low in the tips of Spry2+/+/RetY1062F/Y1062F mice
(Fig. 4C), whereas Spry2−/−/RetY1062F/Y1062F mice exhibited higher
expression of Ret in the tips (Fig. 4D).Distribution of gastrointestinal ganglion cells
To visualize enteric neurons, whole-mount NADPH-diaphorase
(NADPH-d) histochemistry was performed. NADPH-d-positive neu-
rons were distributed from the stomach to the distal colon in wild-
type and Spry2−/−/Ret+/+ mice (Fig. 5Aa–j). However, compared to
wild-type mice, Spry2−/−/Ret+/+ mice had an increased number of
NADPH-d-positive neurons in the digestive tract from the stomach to
the proximal colon (Fig. 5Af–h, 5B, Pb0.05), whereas NADPH-d
positive neurons were signiﬁcantly decreased in number in the
middle and distal colon (Fig. 5Ai, j, and B, Pb0.05).
Consistent with our previous report, Spry2+/+/RetY1062F/Y1062F mice
showed severe ENS defects throughout the digestive tract, especially in
the small intestine and colon, and displayed a sparse distribution of
nerve ﬁbers (Fig. 5Ak–o). In Spry2−/−/RetY1062F/Y1062F mice, the overall
distribution pattern of NADPH-d-positive neuronswas similar to that of
Spry2+/+/RetY1062F/Y1062F mice (Fig. 5Aq–t, compared to l–o). However,
the number of NADPH-d-positive neurons in the stomachs of Spry2−/−/
RetY1062F/Y1062F mice was signiﬁcantly increased compared to that of
Spry2+/+/RetY1062F/Y1062F mice (Fig. 5Ap, compared to Ak, and B,
Pb0.05). These ﬁndings were conﬁrmed by immunostaining with
anti-PGP9.5 antibody (supplementary Fig. 2). Although the number of
NADPH-d-positive neurons, but not of PGP9.5-positive neurons,
showed a signiﬁcant decrease in the middle of colon in Spry2−/−/
Ret+/+ mice compared with in wild-type mice, this may reﬂect
different effects of Spry2 deﬁciency on proliferation/migration of
enteric neurons depending on their subtype, or individual differences
of the mice examined.
Fig. 2. Loss of Spry2 partially rescues the renal hypoplasia caused by the Ret Y1062F mutation. We analyzed eight Spry2+/+/Ret+/+ (W/W), eight Spry2−/−/Ret+/+ (Ho/W), seven
Spry2+/+/RetY1062F/Y1062F (W/Ho), and six Spry2−/−/RetY1062F/Y1062F (Ho/Ho) mice. (A) Body weight of mutant mice at P0. (B) Kidney weight of mutant mice at P0. (C) The kidney
weight-to-body weight ratio of mutant mice at P0. (D) The heart weight-to-body weight ratio of mutant mice at P0. Bars indicate the standard deviation. *Pb0.05, **Pb0.01.
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mutant mice
To compare activation of downstream signaling of Ret between
mutantmice, dorsal root ganglia (DRG)were isolated frommutantmice
at P0. Cultured DRG cells, which are known to express Ret (Jijiwa et al.,
2004), were used to investigate GDNF-mediated Ret signaling, because
DRG cells have the same embryonic origin (the neural crest) as enteric
neurons and a similar number of neurons were obtained from DRG
cultures of four genotypes. The levels of Ret expressionwere almost the
samebetweenwild-type andmutantDRG cells (Fig. 6). Erk activationby
GDNF increased in DRG cells from Spry2−/−/Ret+/+mice and decreased
in DRG cells from Spry2+/+/RetY1062F/Y1062F mice compared with in
those fromwild-typemice (Fig. 6). In addition, Erk activation increased
in DRG cells from Spry2−/−/RetY1062F/Y1062F mice compared with in
those from Spry2+/+/RetY1062F/Y1062F mice, indicating that Spry2
negatively regulates the Erk signaling cascade in vivo.
On the other hand, Akt activation was impaired by Ret Y1062F
mutation but was not affected by the loss of Spry2 (Fig. 6). Although
JNK activation by GDNF was also investigated, it was not apparent in
DRG cells under our experimental conditions (data not shown).
Discussion
It has beenestablished thatGDNF/RET signalingplays a crucial role in
the development of the kidney and the enteric nervous system
(Cacalano et al., 1998; Moore et al., 1996; Pichel et al., 1996; Sánchez
et al., 1996; Schuchardt et al., 1994). Ret Y1062F homozygous knock-in
mice (Y1062F mice), in which tyrosine 1062 in Ret was replaced with
phenylalanine, exhibited hypoplasia of the kidney and defects in the
ENS due to impairment of downstream signaling of Ret (Jijiwa et al.,
2004). On the contrary, Spry2−/− mice displayed enteric nerve
hyperplasia and GDNF-mediated hyperactivation of ERK in entericnerve cells (Taketomi et al., 2005), demonstrating that Spry2 negatively
regulates ERK activation downstream of the GDNF/RET signaling
system. To further elucidate the role of Spry2 in GDNF/RET signaling,
we generated Spry2−/−/Ret Y1062F/Y1062F double mutant mice. Although
it has been previously reported that approximately 50% of Spry2−/−
mice survived longer than 6 weeks after birth (Taketomi et al., 2005),
more than 60% of Spry2−/−/RET+/+mice diedwithin 1 day after birth in
our study. Spry2−/−/RetY1062F/Y1062F mice showed a survival rate trend
similar to that of Spry2−/−/RET+/+ mice. Although the reason for
acceleration of death of Spry2−/−/RET+/+mice has not been clariﬁed at
present, it is possible that this might be due to the change of genetic
background, which resulted from crossing with Ret Y1062F knock-in
mice (C57BL/6 background).
Spry2−/−/RET+/+ mice did not show any marked differences in the
size andhistologyof thekidney comparedwithwild-typemice. Spry2+/+/
RetY1062F/Y1062F mice showed hypoplasia of the kidney as reported
previously (Jijiwa et al., 2004). In Spry2−/−/RetY1062F/Y1062F mice, kidney
size was signiﬁcantly larger than that of Spry2+/+/RetY1062F/Y1062F mice,
accompanied by an increase of ureteric bud branching in the developing
kidney. It has been reported that ERK1/2 is physiologically active in
ureteric buds of the developing mouse kidney and that inhibition of ERK
activationwith theMAP kinase kinase (MEK) inhibitor, PD98059, reduces
ureteric bud branching in a dose-dependent manner (Fisher et al., 2001).
Therefore,we investigated thephosphorylation level of ERK in theureteric
buds in each genotype. In Spry2−/−/RetY1062F/Y1062F mice, the level of
phosphorylated ERK was higher than that of Spry2+/+/RetY1062F/Y1062F
mice. This implies that loss of Spry2 de-represses ERK activation in the
ureteric buds of Spry2−/−/RetY1062F/Y1062F mice. Spry2−/−/RET+/+ mice
exhibited a similar degree of ERK phosphorylation as that seen in
wild-type mice. Although targeted expression of human Spry2 in the
mouse ureteric bud led to a reduction in kidney size with a decrease of
ureteric bud branches (Chi et al., 2004), the size of Spry2−/−/RET+/+
kidney was almost the same as a wild-type kidney. Thus, loss of Spry2
Fig. 3. Histological ﬁndings of mutant mouse kidneys at P0. (A) Cortex area of each mutant kidney at P0. Arrowheads indicate ureteric bud tips. Insets show higher magniﬁcations of
boxed areas. The double-headed arrows indicate the subcapsular domain of each mutant kidney. Scale bars, 50 μm. (B) Quantitative analysis of ureteric bud branching. Numbers of
ureteric bud tips seen in the largest sections of three mutant kidneys were counted. Bars indicate the standard deviation. (C) Quantitative analysis of the thickness of the subcapsular
domain in mutant kidneys. Thickness of 20 subcapsular domains in three mutant kidneys of each genotype was measured. Bars indicate the standard deviation. *Pb0.05, **Pb0.01.
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fact that Erkphosphorylation increased in theureteric budsof Spry2−/−/
RetY1062F/Y1062F mice compared with Spry2+/+/RetY1062F/Y1062F mice
suggests that regulation of Erk activity by Spry2 alters depending on
pathological conditions.
Spry2+/+/RetY1062F/Y1062F mice showed a thicker subcapsular
domain than wild-type mice, and this phenotype was signiﬁcantly
rescued in Spry2−/−/RetY1062F/Y1062F mice. This ﬁnding implies that
ureteric bud ends were positioned abnormally at a distance from the
renal capsule probably due to the impaired branching. It is well-
known that the interaction between ureteric buds and metanephric
mesenchyme is indispensable for kidney development. Retinoids
signal via nuclear transcription factors belonging to the retinoic acid
receptor (RAR) and retinoid X receptor (RXR) families in stromal cellsand play a crucial role in renal morphogenesis (Batourina et al., 2001).
It has been reported that RARα β2 KO mice show a decrease in
ureteric bud branching and display a dense subcapsular layer of the
kidney. In addition, Ret expression was low in ureteric buds of
RARαβ2 KO mice (Mendelsohn et al., 1999), leading to small kidneys.
These phenotypes are similar to Spry2+/+/RetY1062F/Y1062F mice, which
was rescued in Spry2−/−/RetY1062F/Y1062F mice. The decrease of
ureteric bud branching in Spry2+/+/RetY1062F/Y1062F mice may result
in impaired metanephric mesenchymal differentiation.
Ret expression in ureteric buds of Spry2+/+/RetY1062F/Y1062F mice
was signiﬁcantly lower than that in wild-type mice. Since it has been
reported that Ret activation regulates its own expression (Jijiwa et al.,
2008; Kodama et al., 2004; Peterson and Bogenmann, 2004), it seems
likely that impairment of signaling via tyrosine 1062 in Ret down-
Fig. 4. Expression of phospho-Erk and Ret in ureteric buds. Immunohistochemical analyses of each mutant kidney at P0. The serial sections were immunostained with an anti-Ret
antibody (A–D) or an anti-phosphoErk antibody (E–F). Insets show higher magniﬁcations of boxed areas. Milder staining of Ret and pErk in Spry2+/+/RetY1062F/Y1062F mice
compared to other genotypes suggests a decrease in ErK signaling, which could lead to decreased number of ureteric bud tips in Spry2+/+/Ret Y1062F/Y1062F mice shown in Fig. 3B.
Scale bars, 50 μm.
165R. Miyamoto et al. / Developmental Biology 349 (2011) 160–168regulates its own expression. In addition, compared with Spry2+/+/
RetY1062F/Y1062F mice, Spry2−/−/RetY1062F/Y1062F mice showed in-
creased expression of Ret in the ureteric buds. Taken together, with
an increased level of phosphorylation, our ﬁndings suggest that Ret
expression was increased by positive feedback via ERK activation inureteric buds of Spry2−/−/RetY1062F/Y1062F mice. On the other hand, we
did not observe signiﬁcant differences in Ret expression and Erk
phosphorylation in neurons of the stomach between newborn wild-
type and mutant mice (supplementary Fig. 3). Erk may be activated in
these neurons by signaling pathways other than GDNF/RET signaling.
Fig. 5.Defect of the enteric nervous system inmutantmice. (A)Whole-mount NADPH-diaphorase (NADPH-d) histochemistry of the gastrointestinal tract at P0. Views in the stomach
(pylorus), small intestine, proximal colon, middle colon, and distal colon are shown. (B) NADPH-d neurons were counted at each region of the digestive tracts. *Pb0.05.
166 R. Miyamoto et al. / Developmental Biology 349 (2011) 160–168In addition, Ki67- or caspase-3-positive cells were hardly detected in
these neurons (data not shown). These ﬁndings suggest that neurons
in the stomach of newborn mice do not actively proliferate and
migrate. Precise roles of Spry2 downstream of Ret signaling in the
development of the ENS would be elucidated by investigating
proliferation and migration of enteric neuron progenitor cells at
earlier stages of gut development in mutant mice.
Spry2−/−/RET+/+ mice showed hyperganglionosis in the stomach,
small intestine, and proximal colon, which was caused by hyperactiva-
tion of the ERK pathway resulting from loss of Spry2-mediated
suppression (Taketomi et al., 2005). This phenotype is in contrast to
the normal phenotype of the kidney in Spry2−/−/RET+/+ mice and
implies that the regulatory manner of Spry2 in ENS may be differentfrom that in the kidney. In spite of the excess number of ganglion cells,
the neural network appeared to be well organized in Spry2−/−/RET+/+
mice. However, it was unexpected that the number of enteric neurons
was markedly decreased in the distal colon. It is possible that this
decrease of enteric neurons in the distal portions of the colonwas due to
an impaired migration of the enteric progenitor cells. Proper activation
of ERK may be required to orchestrate the normal proliferation and
migration of enteric neural crest cells during embryogenesis.
The overall rescue effect of Spry2 in the ENS was moderate and was
restricted to the stomach.We found that GDNF-mediated Akt activation
was impaired byRet Y1062Fmutationbutwasnot rescued by the loss of
Spry2 (Fig. 6). Since it has beenwell established that PI3-K/Akt signaling
plays a crucial role in cell proliferation andmigration, impairment of Akt
Fig. 6. Ret expression and Erk and Akt activation in dorsal root ganglia cells. Dorsal root
ganglia cells were dissected from P0 wild-type and mutant mice cultured for 72 h. The
lysates from GDNF-treated (100 ng/ml, 15 min) and untreated cells were immuno-
blotted with the indicated antibodies. Erk activation by GDNF increased in DRG cells
from Spry2−/−/Ret+/+ mice and decreased in DRG cells from Spry2+/+/RetY1062F/Y1062F
mice compared with in those fromwild-type mice. Erk activation also increased in DRG
cells from Spry2−/−/RetY1062F/Y1062F mice compared with those from Spry2+/+/
RetY1062F/Y1062F mice, indicating that Spry2 negatively regulates Erk signaling in vivo.
On the other hand, Akt activation was impaired by Ret Y1062F mutation but was not
affected by the loss of Spry2.
167R. Miyamoto et al. / Developmental Biology 349 (2011) 160–168signalingmay explain the modest rescue effect in the ENS by the loss of
Spry2 function.
Basson et al. (2005) reported that Spry1 is essential for the regulation
of GDNF signaling in ureteric bud outgrowth. Spry1 knockout mice
developed supernumerary ureteric buds, resulting in multiple ureters
and kidneys. Interestingly, Spry1 knockout/Ret Y1062F knock-in double
mutant mice developed normal kidneys and urinary tracts, indicating
that loss of Spry1 almost totally rescued renal hypogenesis causedby the
Ret Y1062F mutation (Rozen et al., 2009). In contrast, loss of Spry1 did
not rescue the defects in the ENS of Ret Y1062F knock-in mice. Spry1
does not seem to inﬂuence GDNF-mediatedmigration and proliferation
of enteric neuroblasts. These ﬁndings were surprising because both
Spry1 and Spry2 are expressed in ureteric buds (Zhang et al., 2001) and
enteric neurons of the myenteric plexus (Rozen et al., 2009). Thus, it
appears that physiological functions of each Spry family member differ
in the kidney and the ENS. In addition, it is also possible that the loss of
Spry1or Spry2 function causes hyperactivation of anRTKother thanRet,
leading to the increase in ureteric bud branching and proliferation of
enteric neurons in Ret mutant mice.
In the present study, we demonstrated that Spry2 regulates
GDNF/RET signaling in the developing kidney and ENS in the stomach.
To explain how Spry2 regulates RET signaling in each tissue, a more
detailed investigation is required at the cellular and in vivo levels.
Supplementary data to this article can be found online at
doi:10.1016/j.ydbio.2010.11.002.
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